FDA allows expanded use of Takeda's Velcade

06/23/2008 | Bloomberg

Takeda Pharmaceutical Co. Ltd. has obtained FDA clearance to market Velcade -- acquired through its $8.8 billion takeover of Millennium Pharmaceuticals in May -- as an initial treatment for patients with multiple myeloma. The additional approval is based on study results showing that Velcade helped 35% of people newly diagnosed with the blood cancer experience remission.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Assistant General Counsel, Regulatory
Cardinal Health
Waukegan, IL
Chief Executive Officer
UCare Minnesota
Minneapolis, MN